{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:21:48Z","timestamp":1793308908170,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T00:00:00Z","timestamp":1721433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T00:00:00Z","timestamp":1721433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82360735"],"award-info":[{"award-number":["82360735"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"crossref","award":["20232BAB206137"],"award-info":[{"award-number":["20232BAB206137"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Science and technology project of Jiangxi Provincial Administration of Traditional Chinese Medicine","award":["2023B1340"],"award-info":[{"award-number":["2023B1340"]}]},{"name":"The First Affiliated Hospital of Nanchang University youth talent training Fund","award":["YFYPY202275"],"award-info":[{"award-number":["YFYPY202275"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-67882-1","type":"journal-article","created":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T10:01:34Z","timestamp":1721469694000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Emodin alleviates cholestatic liver injury by modulating Sirt1\/Fxr signaling pathways"],"prefix":"10.1038","volume":"14","author":[{"given":"Zhi","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,20]]},"reference":[{"issue":"2","key":"67882_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S2468-1253(19)30342-5","volume":"5","author":"SK Sarin","year":"2020","unstructured":"Sarin, S. K. et al. Liver diseases in the Asia-Pacific region: A lancet gastroenterology and hepatology commission. Lancet Gastroenterol. Hepatol. 5(2), 167\u2013228. https:\/\/doi.org\/10.1016\/S2468-1253(19)30342-5 (2020).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"67882_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2017.06.020","volume":"47","author":"A Floreani","year":"2018","unstructured":"Floreani, A. & Mangini, C. Primary biliary cholangitis: Old and novel therapy. Eur. J. Intern. Med. 47, 1\u20135. https:\/\/doi.org\/10.1016\/j.ejim.2017.06.020 (2018).","journal-title":"Eur. J. Intern. Med."},{"issue":"7","key":"67882_CR3","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1111\/liv.14153","volume":"39","author":"M Kummen","year":"2019","unstructured":"Kummen, M. & Hov, J. R. The gut microbial influence on cholestatic liver disease. Liver Int. 39(7), 1186\u20131196. https:\/\/doi.org\/10.1111\/liv.14153 (2019).","journal-title":"Liver Int."},{"key":"67882_CR4","doi-asserted-by":"publisher","first-page":"938","DOI":"10.3389\/fphar.2017.00938","volume":"8","author":"JS Wu","year":"2017","unstructured":"Wu, J. S. et al. Huangqi decoction alleviates alpha-naphthylisothiocyanate induced intrahepatic cholestasis by reversing disordered bile acid and glutathione homeostasis in mice. Front. Pharmacol. 8, 938. https:\/\/doi.org\/10.3389\/fphar.2017.00938 (2017).","journal-title":"Front. Pharmacol."},{"key":"67882_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jep.2017.07.031","volume":"209","author":"L Xu","year":"2017","unstructured":"Xu, L. et al. Analyzing the hepatoprotective effect of the Swertia cincta Burkillextract against ANIT-induced cholestasis in rats by modulating the expression of transporters and metabolic enzymes. J. Ethnopharmacol. 209, 91\u201399. https:\/\/doi.org\/10.1016\/j.jep.2017.07.031 (2017).","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"67882_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","volume":"15","author":"W Jia","year":"2018","unstructured":"Jia, W., Xie, G. & Jia, W. Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. Nat. Rev. Gastroenterol. Hepatol. 15(2), 111\u2013128. https:\/\/doi.org\/10.1038\/nrgastro.2017.119 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"67882_CR7","doi-asserted-by":"publisher","first-page":"154173","DOI":"10.1016\/j.phymed.2022.154173","volume":"102","author":"J Liu","year":"2022","unstructured":"Liu, J. et al. Oleanolic acid alleviates ANIT-induced cholestatic liver injury by activating Fxr and Nrf2 pathways to ameliorate disordered bile acids homeostasis. Phytomedicine 102, 154173. https:\/\/doi.org\/10.1016\/j.phymed.2022.154173 (2022).","journal-title":"Phytomedicine"},{"key":"67882_CR8","doi-asserted-by":"publisher","first-page":"153629","DOI":"10.1016\/j.phymed.2021.153629","volume":"90","author":"L Kong","year":"2021","unstructured":"Kong, L. et al. Yangonin modulates lipid homeostasis, ameliorates cholestasis and cellular senescence in alcoholic liver disease via activating nuclear receptor FXR. Phytomedicine 90, 153629. https:\/\/doi.org\/10.1016\/j.phymed.2021.153629 (2021).","journal-title":"Phytomedicine"},{"issue":"1","key":"67882_CR9","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1042\/BST20210658","volume":"50","author":"A Molinaro","year":"2022","unstructured":"Molinaro, A. & Marschall, H. U. Bile acid metabolism and FXR-mediated effects in human cholestatic liver disorders. Biochem. Soc. Trans. 50(1), 361\u2013373. https:\/\/doi.org\/10.1042\/BST20210658 (2022).","journal-title":"Biochem. Soc. Trans."},{"key":"67882_CR10","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/164_2019_231","volume":"256","author":"V Keitel","year":"2019","unstructured":"Keitel, V., Droge, C. & Haussinger, D. Targeting FXR in cholestasis. Handb. Exp. Pharmacol. 256, 299\u2013324. https:\/\/doi.org\/10.1007\/164_2019_231 (2019).","journal-title":"Handb. Exp. Pharmacol."},{"issue":"5","key":"67882_CR11","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1002\/hep.26971","volume":"59","author":"JL Garcia-Rodriguez","year":"2014","unstructured":"Garcia-Rodriguez, J. L. et al. SIRT1 controls liver regeneration by regulating bile acid metabolism through farnesoid X receptor and mammalian target of rapamycin signaling. Hepatology 59(5), 1972\u20131983. https:\/\/doi.org\/10.1002\/hep.26971 (2014).","journal-title":"Hepatology"},{"issue":"12","key":"67882_CR12","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1038\/s41401-018-0110-y","volume":"39","author":"SY Wu","year":"2018","unstructured":"Wu, S. Y. et al. 18beta-glycyrrhetinic acid protects against alpha-naphthylisothiocyanate-induced cholestasis through activation of the Sirt1\/FXR signaling pathway. Acta Pharmacol. Sin. 39(12), 1865\u20131873. https:\/\/doi.org\/10.1038\/s41401-018-0110-y (2018).","journal-title":"Acta Pharmacol. Sin."},{"key":"67882_CR13","doi-asserted-by":"publisher","first-page":"173269","DOI":"10.1016\/j.ejphar.2020.173269","volume":"882","author":"N Hu","year":"2020","unstructured":"Hu, N., Liu, J., Xue, X. & Li, Y. The effect of emodin on liver disease\u2014comprehensive advances in molecular mechanisms. Eur. J. Pharmacol. 882, 173269. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173269 (2020).","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"67882_CR14","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1002\/ptr.5631","volume":"30","author":"X Dong","year":"2016","unstructured":"Dong, X. et al. Emodin: A review of its pharmacology, toxicity and pharmacokinetics. Phytother. Res. 30(8), 1207\u20131218. https:\/\/doi.org\/10.1002\/ptr.5631 (2016).","journal-title":"Phytother. Res."},{"issue":"1","key":"67882_CR15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s10753-021-01529-5","volume":"45","author":"P Shen","year":"2022","unstructured":"Shen, P., Han, L., Chen, G., Cheng, Z. & Liu, Q. Emodin attenuates acetaminophen-induced hepatotoxicity via the cGAS-STING pathway. Inflammation 45(1), 74\u201387. https:\/\/doi.org\/10.1007\/s10753-021-01529-5 (2022).","journal-title":"Inflammation"},{"key":"67882_CR16","doi-asserted-by":"publisher","first-page":"105763","DOI":"10.1016\/j.intimp.2019.105763","volume":"75","author":"L Fang","year":"2019","unstructured":"Fang, L. et al. Anticancer activity of Emodin is associated with downregulation of CD155. Int. Immunopharmacol. 75, 105763. https:\/\/doi.org\/10.1016\/j.intimp.2019.105763 (2019).","journal-title":"Int. Immunopharmacol."},{"key":"67882_CR17","doi-asserted-by":"publisher","first-page":"1589388","DOI":"10.1155\/2022\/1589388","volume":"2022","author":"Y Xia","year":"2022","unstructured":"Xia, Y. et al. Mechanism and active components of Qingre Lidan tablets alleviate intrahepatic cholestasis by activating the Farnesoid X receptor. Evid. Based Complement. Alternat. Med. 2022, 1589388. https:\/\/doi.org\/10.1155\/2022\/1589388 (2022).","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"1","key":"67882_CR18","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1093\/toxsci\/kfy295","volume":"168","author":"X Wang","year":"2019","unstructured":"Wang, X. et al. Paradoxical effects of Emodin on ANIT-induced intrahepatic cholestasis and herb-induced hepatotoxicity in mice. Toxicol. Sci. 168(1), 264\u2013278. https:\/\/doi.org\/10.1093\/toxsci\/kfy295 (2019).","journal-title":"Toxicol. Sci."},{"issue":"5","key":"67882_CR19","doi-asserted-by":"publisher","first-page":"4643","DOI":"10.3892\/mmr.2016.5838","volume":"14","author":"T Yang","year":"2016","unstructured":"Yang, T. et al. Emodin suppresses silica-induced lung fibrosis by promoting Sirt1 signaling via direct contact. Mol. Med. Rep. 14(5), 4643\u20134649. https:\/\/doi.org\/10.3892\/mmr.2016.5838 (2016).","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"67882_CR20","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/kjm2.12476","volume":"38","author":"F Liu","year":"2022","unstructured":"Liu, F., Gu, T. & Wei, D. Emodin alleviates sepsis-mediated lung injury via inhibition and reduction of NF-kB and HMGB1 pathways mediated by SIRT1. Kaohsiung J. Med. Sci. 38(3), 253\u2013260. https:\/\/doi.org\/10.1002\/kjm2.12476 (2022).","journal-title":"Kaohsiung J. Med. Sci."},{"key":"67882_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.fct.2017.09.051","volume":"110","author":"T Yang","year":"2017","unstructured":"Yang, T. et al. Early indications of ANIT-induced cholestatic liver injury: Alteration of hepatocyte polarization and bile acid homeostasis. Food Chem. Toxicol. 110, 1\u201312. https:\/\/doi.org\/10.1016\/j.fct.2017.09.051 (2017).","journal-title":"Food Chem. Toxicol."},{"key":"67882_CR22","doi-asserted-by":"publisher","first-page":"153588","DOI":"10.1016\/j.phymed.2021.153588","volume":"87","author":"F Meng","year":"2021","unstructured":"Meng, F. et al. Dolomiaea souliei ethyl acetate extract protected against alpha-naphthylisothiocyanate-induced acute intrahepatic cholestasis through regulation of farnesoid x receptor-mediated bile acid metabolism. Phytomedicine 87, 153588. https:\/\/doi.org\/10.1016\/j.phymed.2021.153588 (2021).","journal-title":"Phytomedicine"},{"issue":"1","key":"67882_CR23","doi-asserted-by":"publisher","first-page":"4211","DOI":"10.1038\/s41598-017-04536-5","volume":"7","author":"J Yan","year":"2017","unstructured":"Yan, J. et al. Herbal medicine Yinchenhaotang protects against alpha-naphthylisothiocyanate-induced cholestasis in rats. Sci. Rep. 7(1), 4211. https:\/\/doi.org\/10.1038\/s41598-017-04536-5 (2017).","journal-title":"Sci. Rep."},{"key":"67882_CR24","doi-asserted-by":"publisher","first-page":"5061","DOI":"10.2147\/DDDT.S90030","volume":"9","author":"X Ma","year":"2015","unstructured":"Ma, X. et al. Paeonia lactiflora Pall protects against ANIT-induced cholestasis by activating Nrf2 via PI3K\/Akt signaling pathway. Drug Des. Dev. Ther. 9, 5061\u20135074. https:\/\/doi.org\/10.2147\/DDDT.S90030 (2015).","journal-title":"Drug Des. Dev. Ther."},{"key":"67882_CR25","doi-asserted-by":"publisher","first-page":"115164","DOI":"10.1016\/j.jep.2022.115164","volume":"291","author":"M Shi","year":"2022","unstructured":"Shi, M., Tang, J., Zhang, T. & Han, H. Swertiamarin, an active iridoid glycoside from Swertia pseudochinensis H.Hara, protects against alpha-naphthylisothiocyanate-induced cholestasis by activating the farnesoid X receptor and bile acid excretion pathway. J. Ethnopharmacol. 291, 115164 (2022).","journal-title":"J. Ethnopharmacol."},{"issue":"6","key":"67882_CR26","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1002\/hep.28826","volume":"64","author":"SR Kulkarni","year":"2016","unstructured":"Kulkarni, S. R., Soroka, C. J., Hagey, L. R. & Boyer, J. L. Sirtuin 1 activation alleviates cholestatic liver injury in a cholic acid-fed mouse model of cholestasis. Hepatology 64(6), 2151\u20132164. https:\/\/doi.org\/10.1002\/hep.28826 (2016).","journal-title":"Hepatology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-67882-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-67882-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-67882-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T10:02:49Z","timestamp":1721469769000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-67882-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,20]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["67882"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-67882-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4194485\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,20]]},"assertion":[{"value":"31 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16756"}}